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Cervical carcinoma has assumed tremendous 
public health importance globally and is the 
commonest cancer in women in the developing 
1
world . It is second only to the breast as the 
commonest malignancy in women, the 
commonest gynaecological malignancy, and 
the leading cause of gynaecological deaths in 
2, 3
Nigeria . 
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ABSTRACT
Introduction: Cervical cancer is the commonest gynaecological malignancy in Nigeria, 
accounting for most deaths from cancers in women. Screening remains one of the best ways 
to prevent this catastrophe.
Methodology: This was a cross sectional study conducted among patients that presented for 
cervical cancer screening at the Jos University Teaching Hospital, Jos, Plateau State, North 
st stCentral Nigeria over a Five-year period (1  August, 2006-31  July, 2011). Data was analyzed 
for frequencies using EPI Info 3.5.1, CDC, Atlanta, USA.
Results: During the period of study (74.5%) of the 7863 women screened were normal. 
Inflammatory changes, LSIL and HSIL, were the commonest abnormalities.  Eight point 
four percent (8.4.%) were either ASC-US or ASC-H, 35 (0.4%) were AGUS or AGUS-N. 
LSIL and HSIL were 547 (7.0%) and 193 (2.4%) respectively. One thousand, six hundred 
and seventy two (21.2%) were inflammation changes, bacterial infection, or trichomoniasis. 
Thirty two (0.4%) cases of suspected invasive carcinoma were seen.
Conclusion: The abnormal cytological abnormality rate was high. More effort needs to be 
put in place to ensure that women have access to screening to reduce the burden of cervical 
cancer in this environment.
Keywords: Paps smear, intraepithelial changes, cervical cancer, Jos University Teaching 
Hospital.
INTRODUCTION
Corresponding Author. Dr. Patrick Haruna 
Daru. Email: phdaru@yahoo.com 
It presents significant management problems 
for the gynaecologist in this environment as 
most women affected present with the advanced 
stages of the disease when cure is unrealizable, 
hence HPV vaccination and screening offer 
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hope for control .
Cervical screening has emerged as a very 
effective method for the prevention of cervical 
carcinoma. This is because the uterine cervix is 
anatomically accessible. The prolonged, 
premalignant phase has a treatable pre-invasive 
stage, which can be detected by studying the 
cellular characteristics of the exfoliated cells 
(Papaniculaou smear). Studies of cervical 
intraepithelial changes are therefore vital in the 
pursuit of reducing the burden of cervical 
2, 3,6
cancer globally, and Nigeria in particular .
The purpose of this study is aimed at 
reporting the pattern of cytological changes 
seen at the Cervical Cancer Screening Unit of 
the Department of Obstetrics and Gynaecology, 
Jos University Teaching Hospital, Jos, Plateau 
State.
METHODOLOGY
This was a cross sectional study conducted 
among patients that presented for cervical 
cancer screening at the Cervical Cancer Unit 
(CCU) of Jos University Teaching Hospital, 
Jos, Plateau State, North Central Nigeria, over a 
st st
five-year period (1  August, 2006-31  July 
2011). 
The Cervical Cancer Unit was established in 
2006 as collaboration between the Jos 
University Teaching Hospital, and the 
Operation Stop Cervical Cancer in Nigeria 
Project (OSCCN). The OSCCN was a joint 
program between MD Anderson Cancer Centre, 
and grant funded by Exxon-Mobil Foundation.
The clients were either self referred, or were 
referred from the various clinics in JUTH, or 
other clinics/health facilities around Jos, and its 
environs. 
Trained interviewers questioned each client that 
consented to be part of this study. The data was 
entered into a structured pre tested questionnaire 
that was transferred into File Maker Pro, version 
8. The data was analyzed for frequencies using 
EPI Info 3.5.1, CDC, Atlanta, USA.
After clinical and gynaecological examinations 
were performed, cervical smears were obtained 
using bi-valve Graves's speculum to gain access 
to the cervix. Ayres spatula was used to obtain 
specimen from the ecto-cervix, and endocervix. 
Where the endocervix is inaccessible to the 
Ayre's spatula, a cyto-brush was used.
Smears were made on two points on glass slides, 
and then fixed immediately in 95% (v/v) alcohol 
in coupling jars. These were then stained with 
Papanicolau reagent, and then read by the 
Cytopathologist.
The slides were reported as normal, 
inflammatory, Atypical squamous cells of 
undetermined significance (ASC-US), Atypical 
glandular cells of undetermined significance 
( A G C - U S ) ,  L o w - g r a d e  s q u a m o u s  
intraepithelial lesion (LSIL), or High-grade 
squamous intraepithelial lesion (HSIL) 
Approval was obtained from the Ethics 
Committee of the Jos University Teaching 
Hospital, Jos, Nigeria.
Data analysis: Data was analyzed for 
frequencies using EPI Info 3.5.1, CDC, Atlanta, 
USA.
RESULTS
The socio-demographics of the patients showed 
that screening occurred among the 20-50 year 
age group (84.6%) high parity, as well as in the 
numerous ethnicities present on the Jos Plateau 
(Table 1).
Fifty one point one percent had tertiary 
education, 82.4% were married, and 7% were 
single. Forty-four% of the screening occurred 
among the Civil Servants,  Teachers, 
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Businesswomen, and House wives (Table 1)
Risk factors studied showed that 5020 (63.8%) 
had their sexual debut between 15-20 years, 78 
(1%) smoked cigarettes, 568 (7.2%) consumed 
alcohol, while 667 (78.8% of infections) had 
HIV (Table 2).
During the period of study 4743 (60.3%) of the 
7863 women screened were normal, while 3120 
(39.7%) were abnormal. LSIL and HSIL were 
the commonest abnormalities. 
Six hundred and fifty three (8.4%) were either 
ASC-US or ASC-H, 35(0.4%) were AGUS or 
AGUS-N. LSIL and HSIL were 547 (7.0%) and 
193(2.4%) respectively. 
One thousand six hundred and seventy two 
(21.2%) were inflammation changes, bacterial 
infection, or trichomoniasis. Thirty-two (0.4%) 
cases of suspected invasive carcinoma were 
seen (table 2).
Most of the LSIL, and HSIL occurred in the age 
range of 40 to 64 (Table 3).
The mean ages of the patients and the 
cytological abnormalities are as shown in table 
3.
DISCUSSION
This study indicates that the prevalence of 
cervical cytological abnormality is 39.7%.  
This is more than the 13% reported from Ibadan 
and the 29% reported among HIV positive 
1, 2
women from this Centre .
Different cytological cervical epithelial 
changes are detectable using the Paps smear 
7  
cervical screening . Several cytological 
abnormalities were seen.  
Majority 4743 (60.3%) of the women in 
this study had normal smear.  This is within the 
reported range worldwide but higher than the 
reported normal smear rates of 71% in U.S.A 
,1, 2.  and in an earlier study in Jos However, the 
normal smear rate of 60.3% in this study is 
higher than the 36.5% reported in Lagos, but is 
2, 3
lower than the 86% in Jos .  This may be due to 
the large sample size in this study.
The abnormal cervical smear rate of 39.7% 
in this study may be a clear indication for the 
need for routine cervical smear screening among 
our women. This is vital in the reduction of 
2,3, 8
cervical cancer in our environment . The 
pattern of cervical epithelial changes in this 
study is at variance with most studies.  In this 
study, 7.0% had LSIL. This represented majority 
(7.0%) of the abnormal cervical epithelial 
changes outside inflammatory changes, in these 
women. This is lower than the 22.2% reported 
from Jos, but similar to the 7.6% from Okenne in 
  9,10,
Nigeria . This difference may be because of 
differences in the populations studied, and the 
fact that JUTH is a referral Centre for other 
facilities in the zone. 
ASC-US changes were the second 
commonest (6.4%) of the abnormal changes 
seen. However, in an earlier study in Jos, the 
bulk (57.7%) of the abnormal cytology was 
11
ASC-US .
Two point four percent (2.4%) of the 
abnormal changes were from HSIL. This is 
lower than the 20.2% of earlier study in Jos but 
10, 11,
more than 0.5% reported in Okenne .   In this 
study, 0.3% had lesions that favour Neoplasia, 
which is similar to that (0.44%) observed in 
8
Ibadan .  This may be so because both Ibadan, 
and Jos are major centres for screening for 
cervical pre-malignancy in the South, and North 
of Nigeria, hence patients may preferentially 
gravitate to these Centres. 
Twenty one point two percent (21.2%) of the 
total women screened had non- specific 
inflammatory changes. This is important as it 
may justify antibiotic treatment and repeat 
testing in this group of women. In addition, some 
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of these observations may be HPV changes.
There were more abnormal changes in the 
older age group. The mean age for the normal 
smear was 37.3 years, while it was 48.7%, 
46.8% and 48.2% for LSIL, HSIL and 
Carcinoma in situ respectively.  The result from 
this study justifies the view that age is a factor in 
the development of abnormal cervical changes.
It is also important to note that 6.7% and 
4.8% of those with LSIL and HSIL respectively 
were below 30 years of age. This finding 
supports cervical screening for all sexually 
active women, though more frequent screening 
8-14
may be indicated in the older age group .
Because these women availed and utilized 
the screening services in this Centre, those with 
abnormalities were promptly managed 
appropriately, thereby averting the unpleasant 
outcomes.
Cervical screening targeted towards the 
entire population of reproductive age women 
has been highly successful in the developed 
8-10
world . This is not the case in the developing 
world where adult married women largely 
utilize screening programs. This is as a result of 
cultural barriers preventing unmarried and 
young women from accessing the various entry 
points to reproductive health services. The 
result is a large population of sexually active 
young women with poor knowledge and 
utilization of cervical screening that may 
ultimately lead to the development of cervical 
1
cancer
Cytological screening for epithelial 
abnormalities is a valuable intervention for 
prevention of cervical cancer. Globally, most 
abnormalities detected from cervical smears are 
ASC-US and low-grade lesions. In the 
developed, world where awareness and uptake 
of screening cuts across the reproductive age-
groups, cytological abnormalities are more 
prevalent among adolescents compared to adult 
women. In this Centre, uptake of screening by 
the older aged-women was much more than the 
younger women, and abnormalities were seen 
th
more in the 5  decade of life.  Cervical 
cytological abnormality rate of 39.7% was seen.
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Table 1 Socio-Demographic Factors
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Note: ASC-US, atypical squamous cells of 
undetermined significance; ASC-H, atypical 
squamous cells, cannot exclude HSIL; AGUS - 
atypical glandular cells of undetermined 
significance; AGUS–N, atypical glandular cells 
of undetermined significance, cannot exclude 
neoplasia; LSIL, low-grade squamous 
intraepithelial lesion; HSIL, high-grade 
squamous intraepithelial lesion.
★ Others – acute inflammation, bacterial 
infection, trichomoniasis, atrophy, and no 
diagnosis rendered
Overall mean age = 39.8 years
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Total 7863 100
Table 2 Risk Factors and Cytology
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Table 3 Mean Ages Of Various Cytological Changes







AGUS 41.6  
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